These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31560911)

  • 1. Diagnostic value of fusion of metabolic and structural images for stereotactic biopsy of brain tumors without enhancement after contrast medium injection.
    Todeschi J; Bund C; Cebula H; Chibbaro S; Lhermitte B; Pin Y; Lefebvre F; Namer IJ; Proust F
    Neurochirurgie; 2019 Dec; 65(6):357-364. PubMed ID: 31560911
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Patel CB; Fazzari E; Chakhoyan A; Yao J; Raymond C; Nguyen H; Manoukian J; Nguyen N; Pope W; Cloughesy TF; Nghiemphu PL; Czernin J; Lai A; Ellingson BM
    J Neurooncol; 2018 Sep; 139(2):399-409. PubMed ID: 29679199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.
    Karunanithi S; Sharma P; Kumar A; Khangembam BC; Bandopadhyaya GP; Kumar R; Goenka A; Gupta DK; Malhotra A; Bal C
    Eur Radiol; 2013 Sep; 23(9):2628-35. PubMed ID: 23624623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
    J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
    Youland RS; Pafundi DH; Brinkmann DH; Lowe VJ; Morris JM; Kemp BJ; Hunt CH; Giannini C; Parney IF; Laack NN
    J Neurooncol; 2018 May; 137(3):583-591. PubMed ID: 29330751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
    Pafundi DH; Laack NN; Youland RS; Parney IF; Lowe VJ; Giannini C; Kemp BJ; Grams MP; Morris JM; Hoover JM; Hu LS; Sarkaria JN; Brinkmann DH
    Neuro Oncol; 2013 Aug; 15(8):1058-67. PubMed ID: 23460322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of change in maximum
    Oughourlian TC; Yao J; Schlossman J; Raymond C; Ji M; Tatekawa H; Salamon N; Pope WB; Czernin J; Nghiemphu PL; Lai A; Cloughesy TF; Ellingson BM
    J Neurooncol; 2020 Mar; 147(1):135-145. PubMed ID: 31981013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
    Morana G; Piccardo A; Milanaccio C; Puntoni M; Nozza P; Cama A; Zefiro D; Cabria M; Rossi A; Garrè ML
    J Nucl Med; 2014 May; 55(5):718-23. PubMed ID: 24652828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high
    Isal S; Gauchotte G; Rech F; Blonski M; Planel S; Chawki MB; Karcher G; Marie PY; Taillandier L; Verger A
    Br J Radiol; 2018 Apr; 91(1084):20170803. PubMed ID: 29271237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
    Rossi Espagnet MC; Romano A; Mancuso V; Cicone F; Napolitano A; Scaringi C; Minniti G; Bozzao A
    Br J Radiol; 2016 Oct; 89(1066):20160476. PubMed ID: 27505026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
    Karavaeva E; Harris RJ; Leu K; Shabihkhani M; Yong WH; Pope WB; Lai A; Nghiemphu PL; Liau LM; Chen W; Czernin J; Cloughesy TF; Ellingson BM
    Mol Imaging Biol; 2015 Jun; 17(3):434-42. PubMed ID: 25465392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identify glioma recurrence and treatment effects with triple-tracer PET/CT.
    Li C; Yi C; Chen Y; Xi S; Guo C; Yang Q; Wang J; Sai K; Zhang J; Ke C; Chen F; Lv Y; Zhang X; Chen Z
    BMC Med Imaging; 2021 May; 21(1):92. PubMed ID: 34059015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The positive predictive value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment.
    Mehrkens JH; Pöpperl G; Rachinger W; Herms J; Seelos K; Tatsch K; Tonn JC; Kreth FW
    J Neurooncol; 2008 May; 88(1):27-35. PubMed ID: 18217207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
    Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
    J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.
    Hara T; Kondo T; Hara T; Kosaka N
    J Neurosurg; 2003 Sep; 99(3):474-9. PubMed ID: 12959432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.
    Karunanithi S; Sharma P; Kumar A; Gupta DK; Khangembam BC; Ballal S; Kumar R; Kumar R; Bal C
    Eur J Radiol; 2014 Jan; 83(1):219-25. PubMed ID: 24191944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
    Karunanithi S; Sharma P; Kumar A; Khangembam BC; Bandopadhyaya GP; Kumar R; Gupta DK; Malhotra A; Bal C
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1025-35. PubMed ID: 23525498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.